JPS554305A - Remedy for disease caused by stress and its preparation - Google Patents

Remedy for disease caused by stress and its preparation

Info

Publication number
JPS554305A
JPS554305A JP7123678A JP7123678A JPS554305A JP S554305 A JPS554305 A JP S554305A JP 7123678 A JP7123678 A JP 7123678A JP 7123678 A JP7123678 A JP 7123678A JP S554305 A JPS554305 A JP S554305A
Authority
JP
Japan
Prior art keywords
formula
alkyl
remedy
stress
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP7123678A
Other languages
English (en)
Other versions
JPS6121471B2 (ja
Inventor
Jinemon Konishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Zoki Pharmaceutical Co Ltd
Original Assignee
Nippon Zoki Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co Ltd filed Critical Nippon Zoki Pharmaceutical Co Ltd
Priority to JP7123678A priority Critical patent/JPS554305A/ja
Priority to SU782650052A priority patent/SU847916A3/ru
Priority to DE7878100683T priority patent/DE2862404D1/de
Priority to EP78100683A priority patent/EP0006407B1/en
Priority to US05/939,791 priority patent/US4281009A/en
Priority to CA310,821A priority patent/CA1122602A/en
Priority to AU40200/78A priority patent/AU520592B2/en
Publication of JPS554305A publication Critical patent/JPS554305A/ja
Publication of JPS6121471B2 publication Critical patent/JPS6121471B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/74—Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP7123678A 1978-06-13 1978-06-13 Remedy for disease caused by stress and its preparation Granted JPS554305A (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP7123678A JPS554305A (en) 1978-06-13 1978-06-13 Remedy for disease caused by stress and its preparation
SU782650052A SU847916A3 (ru) 1978-06-13 1978-08-16 Способ получени гидантоиновых произ-ВОдНыХ или иХ СОлЕй
DE7878100683T DE2862404D1 (en) 1978-06-13 1978-08-16 Hydantoin derivatives, their preparation and pharmaceutical compositions containing them
EP78100683A EP0006407B1 (en) 1978-06-13 1978-08-16 Hydantoin derivatives, their preparation and pharmaceutical compositions containing them
US05/939,791 US4281009A (en) 1978-06-13 1978-09-05 Hydantoin derivatives
CA310,821A CA1122602A (en) 1978-06-13 1978-09-07 Hydantoin derivatives
AU40200/78A AU520592B2 (en) 1978-06-13 1978-09-26 Hydantoin derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7123678A JPS554305A (en) 1978-06-13 1978-06-13 Remedy for disease caused by stress and its preparation

Publications (2)

Publication Number Publication Date
JPS554305A true JPS554305A (en) 1980-01-12
JPS6121471B2 JPS6121471B2 (ja) 1986-05-27

Family

ID=13454848

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7123678A Granted JPS554305A (en) 1978-06-13 1978-06-13 Remedy for disease caused by stress and its preparation

Country Status (7)

Country Link
US (1) US4281009A (ja)
EP (1) EP0006407B1 (ja)
JP (1) JPS554305A (ja)
AU (1) AU520592B2 (ja)
CA (1) CA1122602A (ja)
DE (1) DE2862404D1 (ja)
SU (1) SU847916A3 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63233946A (ja) * 1986-12-19 1988-09-29 シエル・アグラー・ゲー・エム・ベー・ハー・ウント・コンパニー・カー・ゲー ベンゾフエノンおよびその製法

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4672101A (en) * 1985-09-09 1987-06-09 The Dow Chemical Company Polyepoxy aromatic hydantoins
JPH05262654A (ja) * 1992-03-18 1993-10-12 Kaken Pharmaceut Co Ltd 慢性疲労症候群治療剤
AU754989B2 (en) * 1998-11-16 2002-11-28 Nippon Zoki Pharmaceutical Co., Ltd. A therapeutic agent for intractable vasculitis
JP4711523B2 (ja) 2001-02-13 2011-06-29 日本臓器製薬株式会社 低アルブミン血症改善剤
TWI353979B (en) * 2002-04-10 2011-12-11 Nippon Zoki Pharmaceutical Co Novel crystal form of 5-hydroxy-1-methylhydantoin
WO2003088915A2 (en) * 2002-04-18 2003-10-30 University Of Virginia Patent Foundation Novel sodium channel blockers
US20060241162A1 (en) * 2005-04-20 2006-10-26 Kaoru Okamoto Optically active (R)-hydantoin derivative
US20060241163A1 (en) * 2005-04-20 2006-10-26 Kaoru Okamoto Optically active (S)-hydantoin derivative
US7323536B2 (en) 2005-05-20 2008-01-29 General Electric Company Transparent compositions, methods for the preparation thereof, and articles derived therefrom
US7326764B2 (en) 2005-05-20 2008-02-05 General Electric Company Transparent compositions, methods for the preparation thereof, and articles derived therefrom
ES2769578T3 (es) * 2013-02-12 2020-06-26 Buck Inst Res Aging Hidantoínas que modulan el procesamiento de APP mediado por BACE

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6021151A (ja) * 1983-07-15 1985-02-02 Nisshin Steel Co Ltd 薄板連続鋳造装置

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2409755A (en) * 1946-10-22 Method for obtaining s
CH179695A (de) * 1934-10-30 1935-09-15 Chem Ind Basel Verfahren zur Darstellung eines Hydantoins.
GB644800A (en) * 1940-09-09 1950-10-18 Parke Davis & Co Method for obtaining hydantoins
US2366221A (en) * 1942-03-13 1945-01-02 James J Spurlock 5-substituted-5-(2-thienyl) hydantoins
US2711413A (en) * 1952-11-19 1955-06-21 Indiana University Foundation 5-phenyl-5(3-thienyl)-hydantoin and salts thereof
DE1017172B (de) * 1956-05-19 1957-10-10 Heyden Chem Fab Verfahren zur Herstellung von 5-(p-Bromphenyl)-5-aethylhydantoin bzw. dessen 3-methyl- und 3-oxymethylsubstituierten Derivaten
DE1135915B (de) * 1961-06-29 1962-09-06 Asta Werke Ag Chem Fab Verfahren zur Herstellung neuer, antikonvulsiv wirksamer Spirohydantoine
FR5885M (ja) * 1966-09-23 1968-03-18
US3577520A (en) * 1969-12-19 1971-05-04 Emile Constantin Savini Dentifrice compositions containing 5,5-diaryl - 2,4 -imidazolidinediones and process of treating pyorrhea
CH587903A5 (ja) * 1973-05-07 1977-05-13 Ciba Geigy Ag

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6021151A (ja) * 1983-07-15 1985-02-02 Nisshin Steel Co Ltd 薄板連続鋳造装置

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63233946A (ja) * 1986-12-19 1988-09-29 シエル・アグラー・ゲー・エム・ベー・ハー・ウント・コンパニー・カー・ゲー ベンゾフエノンおよびその製法

Also Published As

Publication number Publication date
AU520592B2 (en) 1982-02-11
CA1122602A (en) 1982-04-27
EP0006407A1 (en) 1980-01-09
US4281009A (en) 1981-07-28
AU4020078A (en) 1980-04-03
DE2862404D1 (en) 1984-06-20
JPS6121471B2 (ja) 1986-05-27
EP0006407B1 (en) 1984-05-16
SU847916A3 (ru) 1981-07-15

Similar Documents

Publication Publication Date Title
JPS554305A (en) Remedy for disease caused by stress and its preparation
ZA857523B (en) Pharmaceutical compositions containing diazepines and having a paf-antagonistic activity
DE3865504D1 (de) 1-phenyl-3-naphthalenyloxy-propanamine.
ES481873A1 (es) Procedimiento para la preparacion de 2-(2-alcoxietil)-2'- hidroxi-6,7-benzomorfanos.
DK33286D0 (da) 6-thioxanthinderivater samt deres anvendelse
ES8601934A1 (es) Un procedimiento para la preparacion de nuevos derivados de triazina.
IE33497B1 (en) Method of preparing substituted or unsubstituted 3-alkoxy-thianaphthene-2-carboxamides
ES469671A1 (es) Procedimiento de preparar derivados de bencimidazol
IE822310L (en) Triazoloquinazolone derivatives
DK685787A (da) Propiophenonderivater til anvendelse ved fremstilling af et laegemiddel til behandling af pollakiuria
SE7704829L (sv) Indazolyl-(4)-oxi-propanolaminer
DK84380A (da) Phenylpiperazinderivater fremgangsmaade til deres fremstilling og deres anvendelse
FR2449677A1 (fr) Nouveaux derives de benzoyl-2 glycylanilides substitues, leur preparation et leur application en tant que medicaments anxiolytiques
IE37043L (en) Pyrimidones
PT74949A (en) Process for the preparation of lysin salts of acid 5-(p-chlorobenzoyl)-1,4-dymetil-pyrrol-2-acetic with analgesic activity
ES460544A1 (es) Procedimiento para la preparacion de nuevos derivados de a- cido 4-fenoxi-alfafenoxialcancarboxilico substituidos en el nucleo.
DK42481A (da) Fremgangsmaade til fremstilling af piperazinderivater af theophyllin
GB1221326A (en) NOVEL 2-ARYLBENZO (b) THIOPHEN-3-(2H)-ONE-1,1-DIOXIDES AND 2-ARYLNAPHTHO(2,3-b) THIOPHEN-3(2H)-ONE-1,1-DIOXIDES
FR2230349A1 (en) 1-Phenyl-2-methyl-5-methoxy indoles - with e.g. sedative, cardiac analeptic, vasodilator, antihypertensive, analgesic, and antiinflammatory activities
IE800900L (en) Pyrrolidinyl-benzoic acid derivatives.
JPS5653658A (en) Pharmaceutical composition having diuretic and hypotensive activity
JPS5538397A (en) Diuretic drug
JPS5690067A (en) Novel heterocyclic ring substituted phenylacetic acid derivative
JPS54109969A (en) Novel method of preparing thiazole derivative
JPS572271A (en) Preparation of 2-aminoindolenine derivative